Abbie Roth

A conversation with Dennis Durbin, MD, MSCE chief scientific officer, Abigail Wexner Research Institute, Nationwide Children’s Hospital

The annual myology course is designed to train the next generation of clinicians and lab scientists in the basics and the latest.

Researchers identify a key regulatory protein implicated in Galgt2 overexpression and begin to elucidate its protective mechanism against muscular dystrophy.

Researchers are investigating the safety and effectiveness of a new gene therapy product that replaces the defective β-sarcoglycan gene.

Genome-wide association study identifies two variants that may yield therapies for children with DMD.